Skip to main content
AIFF logo
AIFF
(NASDAQ)
Firefly Neuroscience, Inc.
$1.31-- (--)
Loading... - Market loading

Firefly Neuroscience (AIFF) Company Profile

Complete business overview, executive team, trading details, and corporate information.

Firefly Neuroscience, Inc.
AIFFNasdaq Stock MarketTechnologySoftware - Application

About Firefly Neuroscience

Firefly Neuroscience, Inc., an artificial intelligence company, develops, markets, and distributes medical devices and technologies that allow high-resolution visualization and evaluation of the complex neurophysiological interconnections of the human brain in North America. The company offers the Evoke System, a system used to perform electroencephalographic (EEG) and event-related potential (ERP) assessments, which are analyzed by its cloud-based platform and returned as structured reports designed to support clinical decision-making for various diseases, including depression, anxiety, ADHD, PTSD, MCI, dementia, Parkinson's disease, bipolar disorder, schizophrenia, schizoaffective disorder, ASD, and traumatic brain injury. It serves clinicians. Firefly Neuroscience, Inc. was founded in 2006 and is based in Kenmore, New York.

Stock Details

ExchangeNasdaq Stock Market (NASDAQ)
CurrencyUSD - USD
TypeStock
SubtypeCommon Stock

Contact Information

Phone888 237 6412
Address
1100 Military Road Kenmore, New York 14217 United States

Corporate Identifiers

CIK0000803578
CUSIP317970101
ISINUS3179701012
EIN54-1167364
SIC7372

Leadership Team & Key Executives

Greg Lipschitz
Chief Executive Officer and Director
David DeCaprio
President, Chief Operating Officer and Director
Paul Krzywicki CPA, CGA
Chief Financial Officer and Company Secretary
Gil Issachar
Chief Technology Officer